Evidence map›Paper›PMID 32635225›Full record

ReviewCancers2020

Characteristics and Outcome of Children with Renal Cell Carcinoma: A Narrative Review.

Justine N van der Beek, James I Geller, Ronald R de Krijger, Norbert Graf, Kathy Pritchard-Jones, Jarno Drost, Arnauld C Verschuur, Dermot Murphy, Satyajit Ray, Filippo Spreafico and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 6 countries.

Justine N van der BeekPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
James I GellerDivision of Oncology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH 45229, USA.
Ronald R de KrijgerPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Norbert GrafDepartment of Pediatric Oncology & Hematology, Saarland University Medical Center and Saarland University Faculty of Medicine, D-66421 Homburg, Germany.
Kathy Pritchard-JonesUCL Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.
Jarno DrostPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Arnauld C VerschuurDepartment of Pediatric Oncology, Hôpital d'Enfants de la Timone, APHM, 13005 Marseille, France.
Dermot MurphyDepartment of Paediatric Oncology, Royal Hospital for Children, Glasgow G51 4TF, Scotland, UK.
Satyajit RayDepartment of Paediatric Oncology, Royal Hospital for Children, Glasgow G51 4TF, Scotland, UK.
Filippo SpreaficoPediatric Oncology Unit, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milano, Italy.
Kristina DzhumaUCL Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.
Annemieke S LittooijPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Barbara SelleDepartment of Pediatric Hematology and Oncology, St. Annastift Children's Hospital, 67065 Ludwigshafen, Germany.
Godelieve A M TytgatPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Marry M van den Heuvel-EibrinkPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Princess Máxima Center · NLRoyal Hospital for Children · GBUniversity College London · GBUtrecht University · NLCincinnati Children's Hospital Medical Center · USFondazione IRCCS Istituto Nazionale dei Tumori · ITHôpital d'Enfants · FROncode Institute · NLSaarland University · DESt. Marien- und St. Annastiftskrankenhaus · DEUniversity Medical Center Utrecht · NL

Funding

Stichting Kinderen Kankervrij 341
6 · The paper itself

Abstract

Pediatric renal cell carcinoma (RCC) is a rare type of kidney cancer, most commonly occurring in teenagers and young adolescents. Few relatively large series of pediatric RCC have been reported. Knowledge of clinical characteristics, outcome and treatment strategies are often based on the more frequently occurring adult types of RCC. However, published pediatric data suggest that clinical, molecular and histological characteristics of pediatric RCC differ from adult RCC. This paper summarizes reported series consisting of ≥10 RCC pediatric patients in order to create an up-to-date overview of the clinical and histopathological characteristics, treatment and outcome of pediatric RCC patients.

Indexed as

outcomepediatricrenal cell carcinomasurvivaltreatment

Identifiers

PMID32635225
PMCPMC7407101
OpenAlexW3038741588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.